首页> 外文期刊>Padjadjaran Journal of Dentistry >Anti-tumor agent celecoxib activity towards SP-C1 tongue cancer cells invasion (in vitro)
【24h】

Anti-tumor agent celecoxib activity towards SP-C1 tongue cancer cells invasion (in vitro)

机译:抗肿瘤药塞来昔布对SP-C1舌癌细胞侵袭的活性(体外)

获取原文
           

摘要

Invasion is a characteristic of the occurrence of cancer and indicates the cancer cells' capability to destroy and degrade the border between the epithet and basal membrane to further spread into the surrounding extra-cellular matrix. The purpose of this research was to find the existence of impediment at the SP-C1 tongue cancer cell using celecoxib chemopreventive medication. The SP-C1 tongue cancer cells were treated in vitro using celecoxib medication as a research subject at the following concentrations 5, 10, 25, 50, 75, 100, 125%; and 0 as control group (only DMEM growth medium treatment). Pure experimental testing was carried out for 24 and 48 hours, with observation and calculation of an average number of SP-C1 tongue cancer cells. The data collected were analyzed using the ANOVA test with Newman Keuls paired range test or t-test. Research results indicated that the average number of SP-C1 tongue cancer cells invasion after administration of celecoxib medication based on administration concentration and time statistically yielded significant results. The ANOVA test results were statistically significant, that is, average occurrence of the number of SP-C1 tongue cancer cells due to the use of celecoxib at certain concentrations compared to that without celecoxib was different. At celecoxib of zero (control) concentration was 24.4 with celecoxib concentration starting at 5 up to 125% experienced a decline from its average 11 to become 2.3. The conclusion of the research was that the greater the celecoxib concentration administered, the greater the effect on the impediment of SP-C1 tongue cancer cell invasion.
机译:侵袭是癌症发生的特征,表明癌细胞破坏和降解上皮与基底膜之间边界的能力,从而进一步扩散到周围的细胞外基质中。这项研究的目的是使用塞来昔布化学预防药物发现SP-C1舌癌细胞存在障碍。使用塞来昔布作为研究对象,以下列5、10、25、50、75、100、125%的浓度体外处理SP-C1舌癌细胞。对照组为0(仅DMEM生长培养基处理)。进行了24和48小时的纯实验测试,观察并计算了SP-C1舌头癌细胞的平均数量。使用ANOVA测试和Newman Keuls配对范围测试或t检验对收集的数据进行分析。研究结果表明,根据给药浓度和时间,塞来昔布药物给药后,SP-C1舌癌细胞的平均侵袭统计学意义显着。 ANOVA测试结果具有统计学意义,即与不使用塞来昔布的情况相比,由于使用一定浓度的塞来昔布导致的SP-C1舌癌细胞的平均发生率有所不同。在塞来昔布为零(对照)浓度为24.4的情况下,塞来昔布浓度从5开始至高达125%,从其平均11下降到2.3。研究的结论是塞来昔布的浓度越大,对SP-C1舌癌细胞侵袭的阻碍作用越大。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号